Pharmaceutical composition for treating atherosclerosis of aorta

Abstract

The invention relates to a pharmaceutical composition for treating atherosclerosis of aorta. The pharmaceutical composition is prepared from the following materials in parts by weight: 100-200 parts of elliptic colysis, 50-150 parts of herb of Chinese goldsaxifrage, 100-200 parts of herb of erectspine sanicle, 100-150 parts of red fruit holly, 50-100 parts of platycodon root, 50-100 parts of Chinese osbeckia herb, 50-100 parts of chrysanthemum, 100-150 parts of stem of smoothfruit ventilago, 50-100 parts of aloe, 50-100 parts of oat, 50-100 parts of stem and leaf of assan crotalaria, 50-150 parts of all-grass of lineolate elatostema, 50-100 parts of honeysuckle, 50-150 parts of root or leaf of apricot plum, 50-100 parts of tuber fleeceflower root, 50-150 parts of herb or root of cypress vine, 100-200 parts of seguin chinkapin root, 100-200 parts of herb of prostrate cyathula, 10-100 parts of pilosecalyx acaulescent pegaeophyton, 50-100 parts of belleric terminalia fruit, 50-100 parts of callery pear, 100-200 parts of stephanotis mucronata and 50-100 parts of liquorice root. The raw materials of the pharmaceutical composition interact and are synergetic, and therefore, the pharmaceutical composition is accurate in curative effect, capable of protecting the cardiovascular system, low in cost and free from toxic and side effects.

Description

technical field [0001] The invention relates to the field of medicine, in particular to a pharmaceutical composition for treating aortic atherosclerosis. Background technique [0002] Atherosclerotic diseases are a large class of diseases that endanger human health, especially cardiovascular and cerebrovascular diseases that seriously threaten human life. In the 1960s, the incidence of atherosclerosis (AS) in developed countries such as Europe and the United States increased significantly and became a common epidemic. With the continuous improvement of living standards in my country, changes in dietary structure and lifestyle, and the arrival of social aging, AS has become one of the main causes of death in my country. For a long time, researchers have been deeply exploring the pathogenesis of AS in order to find effective prevention methods. Modern medicine believes that AS treatment should change bad living habits, smoking cessation, low-fat diet, weight loss, and proper...

AI Technical Summary

Problems solved by technology

Modern medicine believes that AS treatment should change bad living habits, smoking cessation, low-fat diet, weight loss, and proper exercise; the side effects of drugs such as simvastatin and pravastatin and the safety of long-term application need to be further evaluated; interventional therapy still cannot fully Overcoming restenosis and delayed thrombosis after stenting

Images